Le Lézard
Classified in: Health
Subjects: CCA, PET, ANW

Heska First Quarter 2022 Financial Results and Earnings Call Scheduled for May 9, 2022


LOVELAND, Colo., April 18, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its first quarter 2022 financial performance in a press release before the market opens on Monday, May 9, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.

To access the conference call:
    From within the United States, please dial 1-800-239-9838
    From outside of the United States, please dial 1-323-794-2551
    Reference Conference ID: 6552107

The earnings call will be webcast live from the Company's investor relations website at  Heska First Quarter 2022 Earnings Call Webcast.

A telephonic replay will be available at 2 p.m. ET on May 9 through 11:59 p.m. ET on May 23, 2022 and the webcast will be archived on the Company's website for 90 days.

To access the replay by telephone:
    From within the United States, please dial 1-844-512-2921
    From outside the United States, please dial 1-412-317-6671
    Reference Replay Pin Number: 6552107

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.

 

SOURCE Heska Corporation


These press releases may also interest you

at 07:00
Tilray Brands, Inc. , a leading global cannabis-lifestyle and consumer packaged goods company today announced the release of new cannabis flower products added to the Good Supply® ?Bud Squad'. Good Supply's signature Bud Squad product campaign was...

at 07:00
LSL PHARMA GROUP INC. (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the second and final tranche of its private placement financing of Units (as defined hereafter) for $3.8 million representing...

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...



News published on and distributed by: